NM_014276.4(RBPJL):c.132-389T>C AND Type 2 diabetes mellitus
- Germline classification:
- Benign (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000626350.5
Allele description [Variation Report for NM_014276.4(RBPJL):c.132-389T>C]
NM_014276.4(RBPJL):c.132-389T>C
Condition(s)
- Name:
- Type 2 diabetes mellitus
- Synonyms:
- DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; Type II diabetes mellitus; Diabetes mellitus, noninsulin-dependent, late onset
- Identifiers:
- MONDO: MONDO:0005148; MeSH: D003924; MedGen: C0011860; OMIM: 125853; Human Phenotype Ontology: HP:0005978
-
Regulus satrapa voucher NYSM:zo-11259 cytochrome c oxidase subunit I (COX1) gene...
Regulus satrapa voucher NYSM:zo-11259 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2553955117|gb|OR358358.1|Nucleotide
-
Picoides villosus voucher AMNH:DOT-16827 cytochrome c oxidase subunit I (COX1) g...
Picoides villosus voucher AMNH:DOT-16827 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2553954916|gb|OR358277.1|Nucleotide
-
Sphyrapicus varius voucher RAM<CAN>:Z16.5.10 cytochrome c oxidase subunit I (COX...
Sphyrapicus varius voucher RAM<CAN>:Z16.5.10 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2553955241|gb|OR358403.1|Nucleotide
-
Sphyrapicus varius voucher RAM<CAN>:Z95.11.10 cytochrome c oxidase subunit I (CO...
Sphyrapicus varius voucher RAM<CAN>:Z95.11.10 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2553955243|gb|OR358404.1|Nucleotide
-
Picoides villosus voucher RAM<CAN>:Z13.5.5 cytochrome c oxidase subunit I (COX1)...
Picoides villosus voucher RAM<CAN>:Z13.5.5 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2553954901|gb|OR358272.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 16, 2024